Health in Pakistan

1,242 indicators covering health for Pakistan.

IndicatorLatest Year10-yr change Rank
Under-five deaths - Current trends maintained 326,650 2030 down 11.9% 4th
Under-five deaths - SDG target met 176,299 2030 down 46.9% 3rd
Deaths age 10 to 19 - Remains constant 35,947 2030 up 4.3% 4th
Deaths age 10 to 19 - Current trends maintained 29,084 2030 down 12.5% 5th
Mortality caused by road traffic injury 13 per 100,000 population 2019 down 10.3% 106th
Mortality caused by road traffic injury, female 12.6 per 100,000 female population 2019 down 10.6% 51st
Mortality caused by road traffic injury, male 13.4 per 100,000 male population 2019 down 10.1% 131st
Ipv vaccine coverage 87 2024 up 335.0% 126th
Deaths in armed conflicts by country, annual growth rate -74.33 % change on previous year 2026 down 37.4% 8th
Deaths in armed conflicts by region, annual growth rate -74.33 % change on previous year 2026 down 37.4% 8th
Proportion of health care facilities with limited water services 7.06 2025 unchanged 55th
Tb patients living with hiv receiving art 637 2021 up 3,252.6% 43rd
HIV-positive TB patients on ART (antiretroviral therapy) 70.0% 2024 down 30.0% 125th
Hospital beds 6.26 2020 up 47.4% 141st
Treatment success rate for patients treated for MDR-TB 76.0% 2022 up 7.0% 64th
New leprosy case detection rate per 1 000 000 population 0.864 2024 down 68.1% 88th
Treatment success rate: HIV-positive TB cases 92 2023 up 13.6% 19th
Prevalence of wasting, weight for height 7.1% 2018 down 52.3% 28th
Estimated number of children (aged 0-17 years) who have lost one or 6.09 million 2024 up 5.0% 2nd
Weight-for-height <-2 SD 7.09 2018 down 52.5% 28th
Earthquake deaths 42 2021 up 1,300.0% 7th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 82.0% 2025 110th
International Health Regulations core capacity scores, SPAR version 40 2025 112th
Prevalence of underweight, weight for age 23.1% 2018 down 26.4% 9th
Leprosy registered prevalence rate per 1 000 000 population 1.05 2024 down 66.7% 86th
Leprosy - Number of new leprosy cases among children 12 2024 down 65.7% 34th
Leprosy - Number of cases registered for treatment 265 2024 down 54.8% 34th
New leprosy child case detection rate (less than 15 years of age) per 0.13 2024 down 74.5% 62nd
Children (0-14) living with HIV 10,000 2024 up 284.6% 20th
Ipv1 number unvaccinated 901,502 2023 down 81.8% 6th
Children living with hiv 10,000 2024 up 284.6% 20th
Contraceptive prevalence, any method 34.0% 2019 up 25.9% 89th
Number of reported cases of poliomyelitis by wild poliovirus 6 2023 down 70.0% 1st
Age-standardized prevalence of current tobacco use among persons aged 17.9% 2024 down 24.2% 85th
Number of female leprosy new cases 85 2024 down 66.1% 31st
Estimated number of malaria deaths 3,037 2024 up 318.9% 32nd
Estimated number of malaria cases 3.15 million 2024 up 217.2% 23rd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 8 2022 unchanged 1st
Contraceptive prevalence, any modern method 25.0% 2018 up 29.5% 91st
Number of prevalent tuberculosis cases 630,000 2014 down 4.5% 5th
Estimated malaria incidence 12.77 2024 up 170.5% 48th
Estimated malaria mortality rate 1.23 2024 up 257.2% 48th
Number of new G2D leprosy cases 44 2024 down 51.1% 25th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0.175 2024 down 63.9% 70th
3.7.2 Adolescent birth rate per 1,000 women 54 2018 down 4.0% 60th
Proportion of total government spending on essential services, health 0.7% 2015 down 12.7% 116th
3.1.2 Proportion of births attended by skilled health personnel 68 2020 up 65.9% 150th
Inflation-adjusted prices for most sold brand of cigarettes: Prices 2.49 2022 up 57.6% 160th
Taxes as a % of price: total tax 51.8% 2022 down 13.7% 103rd
Taxes as a % of price: value added tax 14.5% 2022 up 5.4% 69th
Taxes as a % of price: ad valorem excise 0.0% 2022 down 100.0% 106th
Taxes as a % of price: specific excise 33.6% 2022 down 20.9% 67th
Taxes as a % of price: import duties 0.0% 2022 38th
Taxes as a % of price: other taxes 3.6% 2022 20th
Vitamin A supplementation coverage rate 90.0% 2023 14th
Inflation-adjusted prices for most sold brand of cigarettes: Price in 110 2022 up 70.1% 73rd
Estimated number of children needing antiretroviral therapy based on 9,600 2025 up 269.2% 21st
Weight-for-height <-3 SD 2.43 2018 down 58.3% 9th
Prevalence of severe wasting, weight for height 2.4% 2018 down 58.6% 8th
Physical activity policies for activie societies 20 2023 down 39.4% 2nd